Chimeric Antigen Receptor (CAR) T cell therapies are a form of immunotherapy that involves engineering a patient’s own T cells to recognize and attack cancer cells. This approach is particularly innovative because it combines the specificity of antibody-based therapy with the cytotoxic potential of T cells.
